Béla Szende

1.1k citations
46 papers · 791 indexed · h-index 16
Topics
Prostate Cancer Treatment and Research (9 papers)Cancer-related Molecular Pathways (6 papers)Prostate Cancer Diagnosis and Treatment (5 papers)

In The Last Decade

Béla Szende

45 papers receiving 764 citations

Peers

Béla Szende
Comparison fields: 5 of 98
  • Molecular Biology 301
  • Oncology 148
  • Reproductive Medicine 102
  • Endocrinology, Diabetes and Metabolism 101
  • Pulmonary and Respiratory Medicine 95
Replace Sei‐Hoon Yang with:
Sei‐Hoon Yang South Korea
Feng Xiao China
Roberto Campagna Italy
Tai‐Lung Cha Taiwan
Rosa Divella Italy
Ferdinand Molnár Finland
Lizhu Lin China
Tsui‐Hsia Feng Taiwan
S. Nilsson Sweden
Béla Szende relative to Sei‐Hoon Yang South Korea Sei‐Hoon Yang's profile →
Citations per field
00.5×5.3×
Sei‐Hoon Yang · 1×
Citations per year

Countries citing papers authored by Béla Szende

Since Specialization
Citations

This map shows the geographic impact of Béla Szende's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Béla Szende with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Béla Szende more than expected).

Fields of papers citing papers by Béla Szende

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Béla Szende. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Béla Szende. The network helps show where Béla Szende may publish in the future.

Co-authorship network of co-authors of Béla Szende

This figure shows the co-authorship network connecting the top 25 collaborators of Béla Szende. A scholar is included among the top collaborators of Béla Szende based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Béla Szende. Béla Szende is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 25
3 19
4 3
5 6
6 19
7 11
8 5
9 6
10 45
11 24
12 13
13 14
14 15
15 48
16 7
17 9
18 23
19 51
20 2

About Béla Szende

Béla Szende is a scholar working on Otorhinolaryngology, Oncology and Endocrinology, Diabetes and Metabolism, having authored 46 papers that have together received 791 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (9 papers), Cancer-related Molecular Pathways (6 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Geriatrics and Gerontology (60 citations), Reproductive Medicine (102 citations) and Otorhinolaryngology (37 citations). Béla Szende has collaborated with scholars based in Hungary, United States and United Kingdom. Frequent co-authors include E. Tyihák, Andrew V. Schally, K. Lapis, Gordan Srkalović, Kate Groot, K. Magyar, Ferenc Perner, Károly Szepesházi, Ferenc Hollósy and Miklós Idei. Their work appears in journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026